[{"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - OtherIntervention group: The intervention group 1, Patients will receive three doses of MSCs. Two doses of 100\u00d710e6 (\u00b110%) cells will intravenously infuse as a normally dropped single dose over 10-12 minutes at the infusion speed of 4-5 mL/minute in day 0 and day 2.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - OtherThe intervention group 3, Patients will receive two doses of MSCs intravenously and EVs. Two doses of 100\u00d710e6 (\u00b110%) MSCs will intravenously infuse as a normally dropped single dose over 10-12 minutes at the infusion speed of 4-5 mL/minute in day 0 and day 2. In days 4 and 6, the patients will receive two times the infusion of MSCs-EVs.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - OtherControl group: Patients will receive conventional therapy", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 787, "treatment_name": "Mesenchymal stem cells", "treatment_type": "Advanced therapy medicinal products (atmp)", "pharmacological_treatment": "Biological treatment"}, {"arm_notes": "", "treatment_id": 1773, "treatment_name": "Mesenchymal stem cell-derived extracellular vesicles (msc-evs)", "treatment_type": "Advanced therapy medicinal products (atmp)", "pharmacological_treatment": "Biological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]